Ayurvedic Management of Ardhavabhedaka (Migraine): A Case Report
International Journal of Innovative Science and Research Technology · 17.08.2026 · 762
DOI: 10.38124/ijisrt/26aug489 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 17.08.2026. Verfasst von Nishu Raina und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Ardhavabhedaka is a classical Ayurvedic disorder of the head characterized predominantly by severe unilateral headache, with clinical features that may overlap with migraine, particularly when accompanied by nausea, vomiting, photophobia, and phonophobia. A 41-year-old woman presented with a 2-year history of recurrent, severe, left-sided throbbing headache associated with nausea, vomiting, photophobia, phonophobia, and osmophobia. Her relevant medical history included hypertension for 10 years and type 2 diabetes mellitus for 5 years. Clinical examination was largely unremarkable apart from facial pallor; the recorded blood pressure was 130/90 mmHg and oxygen saturation was 94%. Based on the clinical presentation and Ayurvedic assessment, the condition was diagnosed as Ardhavabhedaka with migraine-like features. The patient was treated with a multimodal Ayurvedic regimen consisting of Bala Guduchayadi Taila administered as Marsha Nasya (3 mL in each nostril), along with oral Pathyadi Kwatha 25 mL twice daily and Shirsooladi Vajra Rasa two units twice daily for 28 days. Following treatment, the case record documented a marked reduction in the frequency and severity of headache episodes, resolution of nausea and vomiting, and substantial reduction in photophobia and phonophobia. No standardized quantitative headache or disability scale was documented in the source record. This case demonstrates an association between a 28-day multimodal Ayurvedic intervention and symptomatic improvement in a patient presenting with Ardhavabhedaka and migrainelike features. However, the findings should be interpreted cautiously because of the single-case design, absence of a comparator, lack of standardized quantitative outcome measures, and inability to attribute the observed improvement to any individual component of the treatment regimen. Further systematically documented clinical studies are warranted to evaluate the therapeutic potential and safety of this approach.
Zitieren
APA
Raina, N., & Modi, K. (2026). Ayurvedic Management of Ardhavabhedaka (Migraine): A Case Report. International Journal of Innovative Science and Research Technology, 762. https://doi.org/10.38124/ijisrt/26aug489
Vancouver
Raina N, Modi K. Ayurvedic Management of Ardhavabhedaka (Migraine): A Case Report. International Journal of Innovative Science and Research Technology. 2026:762. doi:10.38124/ijisrt/26aug489
BibTeX
@article{Raina2026,
author = {Raina, Nishu and Modi, Kunal},
title = {Ayurvedic Management of Ardhavabhedaka (Migraine): A Case Report},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {762},
doi = {10.38124/ijisrt/26aug489}
}
EUVIMED